YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023, at 3:30 p.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 60 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
CHICAGO, IL / ACCESSWIRE / April 5, 2024 / The American College of Osteopathic Family…
Vancouver, British Columbia--(Newsfile Corp. - April 5, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
PALO ALTO, Calif.--(BUSINESS WIRE)--#DiabetesData--Tidepool, a software company committed to innovations in diabetes management, is thrilled…
FORT COLLINS, CO / ACCESSWIRE / April 5, 2024 / Pathways Hospice recently named Dr.…
DUBLIN--(BUSINESS WIRE)--The "United States Clinical Oncology Next Generation Sequencing Market, By Region, By Competition Forecast…
LAS VEGAS, NV / ACCESSWIRE / April 5, 2024 / All Care Therapies, a leading…